General Information of the Compound
Compound ID |
CP0082868
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
1-([1,3]oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one
Show/Hide
|
||||||||||||||||||
Synonyms |
1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one
1-OXAZOLO[4,5-B]PYRIDIN-2-YL-1-DODECANONE
1-[1,3]oxazolo[4,5-b]pyridin-2-yldodecan-1-one
1312AH
288862-73-7
ACM288862737
AKOS027301548
BDBM50350547
CHEMBL257307
HMS3649B18
MolPort-009-018-944
SCHEMBL3964457
SR-01000946699
ZINC34803705
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C18H26N2O2
|
||||||||||||||||||
Molecular Weight |
302.418
|
||||||||||||||||||
Canonical SMILES |
CCCCCCCCCCCC(=O)c1nc2ncccc2o1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C18H26N2O2/c1-2-3-4-5-6-7-8-9-10-12-15(21)18-20-17-16(22-18)13-11-14-19-17/h11,13-14H,2-10,12H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
XUWBDQAPIZBSRY-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( 1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one )
Drug Name | 1-(oxazolo[4,5-b]pyridin-2-yl)dodecan-1-one |
---|